Abstract
The emergence of the CRISPR/Cas9 system has ushered in a new era of genetic editing with vast implications for both therapeutic interventions and drug discovery. This essay explores the extent to which CRISPR/Cas9 elevates target efficiency and revolutionizes drug discovery. While this technology offers unprecedented efficiency, precision, and programmability in genome editing, concerns about off-target effects have arisen. The essay discusses the transformative impact of CRISPR/Cas9 in drug discovery, particularly in cancer research and combating antimicrobial resistance. It also highlights strategies for detecting and mitigating off-target effects, such as in silico prediction tools, experimental methods, and precision-enhancing techniques. Ultimately, CRISPR/Cas9’s potential is undeniable, but its full realization depends on ongoing research and refinement to optimize specificity and revolutionize the field of drug discovery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Transactions on Materials, Biotechnology and Life Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
